SCM
OM icon

Silvant Capital Management’s Outset Medical OM Stock Holding History

Silvant Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-240
Closed -$57K – 335
2022
Q3 		$57K Hold
240
– – ﹤0.01% 306
2022
Q2 		$53K Hold
240
– – 0.01% 262
2022
Q1 		$163K Hold
240
– – 0.03% 184
2021
Q4 		$166K Sell
240
-15
-6% -$11.1K 0.03% 194
2021
Q3 		$189K Hold
255
– – 0.03% 188
2021
Q2 		$191K Hold
255
– – 0.03% 189
2021
Q1 		$208K Buy
+255
New +$197K 0.04% 182

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Silvant Capital Management's OM Position: Q4 2022 in Review

Silvant Capital Management sold out of Outset Medical (OM) in Q4 2022, closing a stake of 240 shares — an estimated $57K sold.

Silvant Capital Management first reported a position in OM in Q1 2021 and held it in 7 quarters. The position peaked at $208K in Q1 2021. 152 funds tracked by Wall St. Rank hold OM as of Q4 2022.

  • Silvant Capital Management reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
  • Silvant Capital Management sold 240 Outset Medical shares in Q4 2022, an estimated $57K.
  • Silvant Capital Management first reported a position in Outset Medical in Q1 2021 and held it in 7 quarters.
  • Silvant Capital Management's Outset Medical position peaked at $208K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on Silvant Capital Management's 13F filing for Q4 2022, filed 23 Jan 2023.